GrowthWorks

HIGHLINE is a pre-seed investor and acceleration platform that supports digital startups in securing follow-on capital, leveraging a network of prominent venture capitalists from its offices in Vancouver and Toronto. Unlike traditional accelerators, HIGHLINE operates without rigid start or end dates, allowing founders to seek advice and support at any time. The platform offers access to a premium network and hosts monthly events for founders, fostering an environment for collaboration and growth. Additionally, HIGHLINE addresses fundraising challenges and collaborates with incubators to provide specialized programming tailored to the needs of emerging companies. The organization was formed in August 2014 through the merger of Growlab Ventures and Extreme Startups.

SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

BuildDirect Technologies Inc. operates an online marketplace that connects homeowners and home improvement professionals in North America with global suppliers of building materials. Founded in 1999 and based in Vancouver, Canada, the company offers a wide range of products, including flooring, decking, tiles, and other building materials. Its platform facilitates the buying and selling of these materials, enhancing accessibility for consumers and professionals alike. BuildDirect's services also include BuildDirect Gateway, a global supply chain platform that provides third parties with access to advanced warehousing and logistics solutions, streamlining the shipping process from manufacturing to last-mile delivery. The company generates the majority of its revenue from its primary platform in the United States.

INETCO Systems Limited is a technology company that specializes in real-time transaction monitoring and customer experience analytics for various sectors, including banking, retail, healthcare, travel, telecommunications, and payment processing. Founded in 1984 and based in Burnaby, Canada, the company provides a range of software solutions designed to enhance the reliability and security of digital and self-service payments. Its flagship product, INETCO Insight, is utilized by banks, payment service providers, and retailers across more than 35 countries to improve digital transformation efforts and quickly identify payment fraud and performance issues. INETCO also offers services such as implementation, training, and transaction analytics, along with solutions for omni-channel banking, ATM monitoring, mobile and online banking, and payment processing.

D-Wave Systems Inc. is a pioneering company in the field of quantum computing, recognized as the world’s first commercial supplier of quantum computers. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave specializes in the development, fabrication, and integration of superconducting quantum computers. The company offers a range of products, including the D-Wave Two System, a commercial quantum computer, and D-Wave Hybrid, an open-source platform for creating hybrid quantum-classical applications. Leap, its cloud-based service, provides real-time access to quantum computing resources along with development tools and educational content. D-Wave’s quantum computers are applied across various sectors, addressing challenges in mission planning, logistics, machine learning, and optimization problems, among others. The company serves diverse industries, including defense, finance, energy, and academia, and also offers professional services, training, and customer support to enhance user experience and application development.

MSI Methylation Sciences, Inc. is a biotechnology company founded in 2007 and based in West Vancouver, Canada. The company focuses on developing oral and small molecule therapies for the adjunctive treatment of Major Depressive Disorder (MDD). Their primary product, Strada, is an orally administered therapy designed to alleviate the symptoms of depression in patients suffering from this condition. Additionally, MSI Methylation Sciences develops S-Adenosyl Methionine, a prescription drug utilized as a dietary supplement, which leverages the capabilities of ademetionine, a naturally occurring molecule integral to the one-carbon cycle in the body. Through its innovative approaches, the company aims to enhance treatment options for individuals facing MDD.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

Boreal Genomics Inc. is a biotechnology company that specializes in the development and marketing of technologies for the blood-based detection and monitoring of circulating tumor DNA. Founded in 2007 and headquartered in Los Altos, California, with an additional office in Vancouver, Canada, the company focuses on improving cancer patient care through innovative diagnostic tools and research applications. Its OnTarget platform enables highly sensitive detection and quantification of tumor mutations in plasma, facilitating accurate tumor profiling and real-time monitoring of tumor evolution. Boreal Genomics also offers the Aurora tool, which purifies and concentrates nucleic acids from various sample types, enhancing the accuracy of sequencing in liquid biopsy applications. These technologies aim to guide therapy selection, improve the efficiency of clinical trials, and accelerate drug development processes.

SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.

Strutta.com Media is a privately held company based in Vancouver, BC, specializing in social media promotion services. The company provides advanced technology that allows brands, agencies, and developers to create and manage interactive contests and sweepstakes through user-friendly, do-it-yourself tools. Strutta has facilitated award-winning promotions for a diverse clientele, including major international agencies and Fortune 500 companies such as Microsoft, AirBNB, and Coca-Cola. By offering tailored social promotion campaigns, Strutta enables brands to effectively connect with their target consumers, driving leads, awareness, and sales. Additionally, the company is recognized as a Facebook Preferred Marketing Developer, highlighting its expertise and credibility in the field of social marketing.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

Mixpo, Inc. is a Seattle-based company that operates a comprehensive advertising platform specializing in social, display, and video advertising. Founded in 2002, Mixpo provides tools for advertisers, agencies, and media companies to create, deliver, and measure digital advertising campaigns effectively. The platform enhances campaign performance by integrating channels, assets, and providing advanced capabilities such as measurement, bid optimization, targeting, and retargeting. It also offers solutions tailored for brand advertisers, local creative services, national networks, and advertising exchanges. Known for its innovative technology and deep data insights, Mixpo facilitates ad verification and performance analysis across various demographics and devices. As of 2017, Mixpo functions as a subsidiary of Netsertive, Inc.

Bootup Labs was a startup accelerator based in Vancouver, Canada, founded in 2008. It focused on assisting early-stage companies, particularly in the digital media sector, in becoming fundable ventures. The organization recruited promising entrepreneurs and provided them with essential resources, including mentorship, ongoing support, investment, and office space. Through its comprehensive approach, Bootup Labs aimed to help startups define their business models and secure venture financing, ultimately guiding eight companies from inception to a state of readiness for funding.

Inimex Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of innate defense regulators (IDRs). These innovative agents are designed to selectively modulate the body's innate immune responses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, mitigate tissue damage, and decrease the risk of bacterial infections. Inimex's IDRs are intended for the treatment of various infections and conditions related to tissue injury, including ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is focused on advancing its clinical-stage products to improve patient outcomes.

Strutta.com Media is a privately held company based in Vancouver, BC, specializing in social media promotion services. The company provides advanced technology that allows brands, agencies, and developers to create and manage interactive contests and sweepstakes through user-friendly, do-it-yourself tools. Strutta has facilitated award-winning promotions for a diverse clientele, including major international agencies and Fortune 500 companies such as Microsoft, AirBNB, and Coca-Cola. By offering tailored social promotion campaigns, Strutta enables brands to effectively connect with their target consumers, driving leads, awareness, and sales. Additionally, the company is recognized as a Facebook Preferred Marketing Developer, highlighting its expertise and credibility in the field of social marketing.

D-Wave Systems Inc. is a pioneering company in the field of quantum computing, recognized as the world’s first commercial supplier of quantum computers. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave specializes in the development, fabrication, and integration of superconducting quantum computers. The company offers a range of products, including the D-Wave Two System, a commercial quantum computer, and D-Wave Hybrid, an open-source platform for creating hybrid quantum-classical applications. Leap, its cloud-based service, provides real-time access to quantum computing resources along with development tools and educational content. D-Wave’s quantum computers are applied across various sectors, addressing challenges in mission planning, logistics, machine learning, and optimization problems, among others. The company serves diverse industries, including defense, finance, energy, and academia, and also offers professional services, training, and customer support to enhance user experience and application development.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.

Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

D-Wave Systems Inc. is a pioneering company in the field of quantum computing, recognized as the world’s first commercial supplier of quantum computers. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave specializes in the development, fabrication, and integration of superconducting quantum computers. The company offers a range of products, including the D-Wave Two System, a commercial quantum computer, and D-Wave Hybrid, an open-source platform for creating hybrid quantum-classical applications. Leap, its cloud-based service, provides real-time access to quantum computing resources along with development tools and educational content. D-Wave’s quantum computers are applied across various sectors, addressing challenges in mission planning, logistics, machine learning, and optimization problems, among others. The company serves diverse industries, including defense, finance, energy, and academia, and also offers professional services, training, and customer support to enhance user experience and application development.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

QuIC Financial Technologies, Inc. specializes in developing advanced simulation, risk calculation, and pricing platform solutions tailored for financial institutions and companies. The company offers a comprehensive product suite that includes the QuIC Engine, a high-performance desktop calculator capable of supercomputer-level processing, and QuIC Script, a vector computing language designed for formulating financial solutions. Additionally, QuIC Analytics delivers a range of analytical tools for various financial instruments, including derivatives, equities, and structured products. The company also provides QuIC Workbench for the customization and visualization of QuIC Script, along with integration products like QuIC Dispatch and QuIC Bridge to enhance interoperability with client systems. QuIC Financial Technologies further extends its services through product support, system integration, custom development, and consulting, addressing various risk management needs including market and credit risk. Founded in 1998 and headquartered in Vancouver, Canada, QuIC also maintains offices in London and New York.

Mixpo, Inc. is a Seattle-based company that operates a comprehensive advertising platform specializing in social, display, and video advertising. Founded in 2002, Mixpo provides tools for advertisers, agencies, and media companies to create, deliver, and measure digital advertising campaigns effectively. The platform enhances campaign performance by integrating channels, assets, and providing advanced capabilities such as measurement, bid optimization, targeting, and retargeting. It also offers solutions tailored for brand advertisers, local creative services, national networks, and advertising exchanges. Known for its innovative technology and deep data insights, Mixpo facilitates ad verification and performance analysis across various demographics and devices. As of 2017, Mixpo functions as a subsidiary of Netsertive, Inc.

Inimex Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of innate defense regulators (IDRs). These innovative agents are designed to selectively modulate the body's innate immune responses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, mitigate tissue damage, and decrease the risk of bacterial infections. Inimex's IDRs are intended for the treatment of various infections and conditions related to tissue injury, including ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is focused on advancing its clinical-stage products to improve patient outcomes.

Inimex Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of innate defense regulators (IDRs). These innovative agents are designed to selectively modulate the body's innate immune responses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, mitigate tissue damage, and decrease the risk of bacterial infections. Inimex's IDRs are intended for the treatment of various infections and conditions related to tissue injury, including ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is focused on advancing its clinical-stage products to improve patient outcomes.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.